Dietary fish oil normalize dyslipidemia and glucose intolerance with unchanged insulin levels in rats fed a high sucrose diet.
The aim of this study was to investigate the relationship between the lipid-lowering effects of fish oils and concomitant consequences on glucose tolerance and insulin sensitivity in an experimental animal model of hypertriglyceridemia induced by high sucrose intake. To achieve this goal, male Wistar rats were fed a semi-synthetic sucrose rich diet (SRD) (w/w: 62.3% sucrose, 8% corn oil, 17% protein) for 90 days. At the time, a well established and permanent hypertriglyceridemia accompanied by glucose intolerance was present. After that, one half of the animals continued on the SRD up to 120 days. The other half received an SRD in which the source of fat was substituted by cod liver oil (w/w 7% CLO plus 1% corn oil) from day 90 to 120 (SRD+CLO). Control rats were fed a semi-synthetic diet (CD) (w/w: 62.5% corn starch, 8% corn oil, 17% protein) throughout the 120 days experimental period. Results obtained after the experimental period show that the hypertriglyceridemia and glucose intolerance ensuing long term feeding normal rats with a sucrose-rich diet could be completely reversed mediating no change in circulating insulin levels by shifting the source of fat in the diet from corn oil to cod liver oil. These findings suggest that manipulation of dietary fats may play a role in the management of the lipid disorders associated with glucose intolerance and insulin resistance.
Lombardo
Y B
YB
Department of Biochemistry, University of Litoral, Ciudad Universitaria Paraje El Pozo, Santa Fe, Argentina.
Chicco
A
A
D'Alessandro
M E
ME
Martinelli
M
M
Soria
A
A
Gutman
R
R
D000818:Animals; D001786:Blood Glucose; D001835:Body Weight; D003060:Cod Liver Oil / Q000627:therapeutic use*; D004040:Dietary Carbohydrates; D004042:Dietary Fats, Unsaturated / Q000627:therapeutic use*; D004435:Eating; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage; D005947:Glucose; D018149:Glucose Intolerance / Q000139:chemically induced / Q000188:drug therapy*; D005951:Glucose Tolerance Test; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008099:Liver / Q000378:metabolism; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014280:Triglycerides / Q000032:analysis / Q000097:blood*
D001786:Blood Glucose; D004040:Dietary Carbohydrates; D004042:Dietary Fats, Unsaturated; D005217:Fat Emulsions, Intravenous; D007328:Insulin; D014280:Triglycerides; D003060:Cod Liver Oil; D005947:Glucose